Rhoda Alani
Affiliations: | Johns Hopkins University, Baltimore, MD |
Area:
Molecular Biology, Cell BiologyGoogle:
"Rhoda Alani"Children
Sign in to add trainee| Staci D. Cummings | grad student | 2008 | Johns Hopkins |
| Megan J. Keefe | grad student | 2009 | Johns Hopkins |
| Courtney F. Silverthorn | grad student | 2009 | Johns Hopkins |
| Whei F. Moriarty | grad student | 2012 | Johns Hopkins |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Soukar I, Fisher RJ, Bhagavatula S, et al. (2025) The CoREST complex is a therapeutic vulnerability in malignant peripheral nerve sheath tumors. Scientific Reports. 15: 10128 |
| Geethadevi A, Vaidya N, Fisher RJ, et al. (2024) The CoREST complex inhibitor, corin, leads to decreased tumor growth, increased cellular differentiation and extended lifespan in atypical teratoid rhabdoid tumor xenograft models. Biorxiv : the Preprint Server For Biology |
| Soukar I, Fisher R, Bhagavatula S, et al. (2024) The CoREST complex is a therapeutic vulnerability in malignant peripheral nerve sheath tumors. Biorxiv : the Preprint Server For Biology |
| Waddell A, Grbic N, Leibowitz K, et al. (2024) p300 KAT Regulates SOX10 Stability and Function in Human Melanoma. Cancer Research Communications. 4: 1894-1907 |
| Waddell A, Grbic N, Leibowitz K, et al. (2024) p300 KAT regulates SOX10 stability and function in human melanoma. Biorxiv : the Preprint Server For Biology |
| Hanly A, Gibson F, Kuang K, et al. (2020) 692 Using a novel p300 HAT inhibitor as epigenetic therapy to treat BRAF inhibitor-resistant melanoma cells Journal of Investigative Dermatology. 140 |
| Anastas JN, Zee BM, Kalin JH, et al. (2019) Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG. Cancer Cell |
| Kim E, Zucconi BE, Wu M, et al. (2019) MITF Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human Melanoma. Cancer Research |
| Kida M, Falanga V, Wu M, et al. (2019) 941 Epigenetic manipulation of epidermal cells leads to enhanced cellular migration without an increase in cell proliferation Journal of Investigative Dermatology. 139: S162 |
| Eisenstein A, Gonzalez EC, Raghunathan R, et al. (2018) Emerging Biomarkers in Cutaneous Melanoma. Molecular Diagnosis & Therapy |